The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus

Prenatal Diagnosis

Volumn 35, Issue 5, 2015, Pages 447-452

  Pagani, Giorgio ^a   Reggia, Rossella ^a   Andreoli, Laura ^a   Prefumo, Federico ^a   Zatti, Sonia ^a   Lojacono, Andrea ^a   Tincani, Angela ^a   Frusca, Tiziana ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE PREGNANCY OUTCOME; ARTICLE; BIRTH WEIGHT; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; FETUS OUTCOME; FOLLOW UP; KIDNEY DISEASE; MEAN UTERINE ARTERY PULSATILITY INDEX; NEWBORN DEATH; OBSERVATIONAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REAL TIME ULTRASOUND SCANNER; RENAL FLARE; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; STILLBIRTH; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE ARTERY DOPPLER; ADULT; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEWBORN; PERINATAL DEATH; PREDICTIVE VALUE; PULSATILE FLOW; RETROSPECTIVE STUDY; UTERINE ARTERY; UTERUS; VASCULARIZATION;

ABRUPTIO PLACENTAE; ADULT; COHORT STUDIES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PERINATAL DEATH; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PULSATILE FLOW; RETROSPECTIVE STUDIES; STILLBIRTH; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY; UTERUS;

EID: 84928424222     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4517     Document Type: Article

References (34)

1. Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv 2011;66(10):639-53.
2. Ruffatti AA, Calligaro AA, Del Ross TT, et al. Risk-based secondary prevention of obstetric antiphospholipid syndrome. Lupus 2012;21(7):741-3.
3. Costedoat-Chalumeau N, Guettrot-Imbert G, Leguern V, et al. Grossesse et syndrome des antiphospholipides. Rev Med Interne 2012;33(4):209-16.
4. Hernandez-Andrade E, Brodszki J, Lingman G, et al. Uterine artery score and perinatal outcome. Ultrasound Obstet Gynecol 2002;19(5):438-42.
5. Stampalija T, Gyte GM, Alfirevic Z. Utero-placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database Syst Rev 2010;9:CD008363.
6. Frusca T, Soregaroli M, Zanelli S, et al. Role of uterine artery Doppler investigation in pregnant women with chronic hypertension. Eur J Obstet Gynecol Reprod Biol 1998;79(1):47-50.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725.
8. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006(4):295-306.
9. Lakos G, Favaloro EJ, Harris EN, et al. International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum 2012;64(1):1-10.
10. Buyon JP, Kalunian KC, Ramsey-Goldman R, et al. Assessing disease activity in SLE patients during pregnancy. Lupus 1999;8(8):677-84.
11. Romero-Diaz J, Isenberg D, Ramsey-Goldman R. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index(SDI) Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S37-46.
12. Robinson HP, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 1975;82(9):702-10.
13. Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32(2):128-32.
14. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Womens Health 2010;2:327-37.
15. Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus 2005;14(1):89-94.
16. Parazzini F, Cortinovis I, Bortolus R, et al. Weight at birth by gestational age in Italy. Hum Reprod. 1995;10(7):1862-3.
17. Ananth CV, Berkowitz GS, Savitz DA, et al. Placental abruption and adverse perinatal outcomes. JAMA 1999;282(17):1646-51.
18. Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 2011;38(9):1906-13.
19. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology 2006;45(3):332-8.
20. Guzman E, Schulman H, Bracero L, et al. Uterine-umbilical artery Doppler velocimetry in pregnant women with systemic lupus erythematosus. J Ultrasound Med 1992;11(6):275-81.
21. Weiner Z, Lorber M, Blumenfeld Z. Umbilical and uterine artery flow velocity waveforms in pregnant women with systemic lupus erythematosus treated with aspirin and glucocorticosteroids. Am J Reprod Immunol 1992;28(3-4):168-71.
22. Madazli R, Yuksel MA, Oncul M, et al. Obstetric outcomes and prognostic factors of lupus pregnancies. Arch Gynecol Obstet 2014;289(1):49-53.
23. Ostensen M, Clowse M. Pathogenesis of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol 2013;25(5):591-6.
24. Tamblyn JA, Lissauer DM, Powell R, et al. The immunological basis of villitis of unknown etiology - Review. Placenta 2013;34(10):846-55.
25. Roncaglia N, Crippa I, Locatelli A, et al. Prediction of superimposed preeclampsia using uterine artery Doppler velocimetry in women with chronic hypertension. Prenat Diagn 2008;28(8):710-4.
26. Nicolaides K. A model for a new pyramid of prenatal care based on the 11 to 13weeks' assessment. Prenat Diagn 2011;31(1):3-6.
27. Costa SL, Proctor L, Dodd JM, et al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta 2008;29(12):1034-40.
28. Herraiz I, Arbués J, Camaño I, et al. Application of a first-trimester prediction model for pre-eclampsia based on uterine arteries and maternal history in high-risk pregnancies. Prenat Diagn 2009;29(12):1123-9.
29. Branch DW, Porter TF, Rittenhouse L, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001;184(5):825-32- discussion 832-4.
30. Chen Q, Guo F, Hensby-Bennett S, et al. Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: implications for the pathogenesis of preeclampsia. Placenta 2012;33(10):810-5.
31. Allen JY, Tapia-Santiago C, Kutteh WH. Antiphospholipid antibodies in patients with preeclampsia. Am J Reprod Immunol 1996;36(2):81-5.
32. Ruffatti A, Tonello M, Visentin MS, et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology 2011;50(9):1684-9.
33. Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005;330(7491):576-80.
34. Bhide A, Acharya G, Bilardo CM, et al. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol 2013;41:233-9.